Greater Munich Metropolitan Area
PreOmics is as a spin-off company from the proteomics pioneer Matthias Mann at the Max-Planck Institute of Biochemistry. PreOmics' set the standard for efficient sample processing and peptide cleanup in the field of LC/MS-based protein analyses. Our mission is to support you with your research to achieve your results faster, easier, and in a more robust manner than ever before.
Building on the combined strengths of the Bruker companies PreOmics, Biognosys, and biocrates, Biognosys Group integrates industry-leading consumables, software, instruments, and CRO services to make advanced mass spectrometry workflows accessible to every laboratory.
PreOmics (www.preomics.com) is as a spin-off company from the proteomics pioneer Matthias Mann at the Max-Planck Institute of Biochemistry. PreOmics' set the standard for efficient sample processing and peptide cleanup in the field of LC/MS-based protein analyses. Our mission is to support you with your research to achieve your results faster, easier, and in a more robust manner than ever before.
Clinical MS-based proteomics Support of commercialization/spin-out activities in Prof. Mann's department as designated co-founder Managing multi-disciplinary R&D collaborations with hospitals and companies
Proteomics
Title: „Crosstalk between DNA methylation and histone modifications“